Related Experiment Video
Updated: Jul 19, 2026

09:46
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct.
Kerstin Imrell1, Anne-Marie Landtblom, Jan Hillert
1Division of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. kerstin.imrell@ki.se
Neurology
|September 27, 2006
Summary
Multiple sclerosis (MS) patients with and without cerebrospinal fluid oligoclonal bands (OCBs) show similar clinical features. However, immunogenetic analysis suggests these groups represent distinct subpopulations in Swedish MS patients.
Area of Science:
- Neurology
- Immunology
- Genetics
Background:
- Multiple sclerosis (MS) is a central nervous system autoimmune disease.
- Oligoclonal bands (OCBs) in cerebrospinal fluid (CSF) are common in MS but their significance in distinct subpopulations is debated.
- Understanding MS heterogeneity is crucial for targeted therapies.
Purpose of the Study:
- To investigate if Swedish MS patients with and without CSF OCBs represent distinct clinical and immunogenetic subpopulations.
- To compare clinical characteristics between OCB-positive and OCB-negative MS.
- To analyze the immunogenetic differences, specifically HLA-DRB1, between these MS groups.
Main Methods:
- Retrospective analysis of Swedish MS patient data.
- Clinical data collection including demographics, disease course, and MRI findings.
- Cerebrospinal fluid (CSF) analysis for oligoclonal bands (OCBs).
- Human Leukocyte Antigen (HLA)-DRB1 genotyping for immunogenetic comparison.
Main Results:
- OCB-negative MS patients exhibited similar clinical features to OCB-positive MS patients, including female predominance, age at onset, primary progressive MS proportion, MRI positivity, and disease severity.
- HLA-DRB1 genotyping revealed significant immunogenetic distinctions between OCB-positive and OCB-negative MS subpopulations.
- These findings suggest a potential divergence in the underlying immunological mechanisms.
Conclusions:
- Clinically, OCB-negative MS appears similar to OCB-positive MS in the studied Swedish cohort.
- Immunogenetically, OCB-positive and OCB-negative MS represent distinct patient groups.
- Further research into the immunogenetic basis of MS subtypes is warranted.

